An Early Phase 1 interventional study of Methyprednisolon and low level laser theraphy in Nerve Injury, Laser Therapy and Methylprednisolone, sponsored by Recep Tayyip Erdogan University. Active, not recruiting at 1 site in Turkey. Open to male participants aged 4 Months to 6 Months, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-01-03.
Sponsored by Recep Tayyip Erdogan University · Early Phase 1, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
The objective of the study will be to investigate the effect of low-level diode laser therapy (LLLT) and steroid on facial nerve injury. Thirty five male Wistar rat will randomly be divided into five groups: healthy control (HCG); damage control (DC); laser (LG); steroid (SG); and combined laser and steroid group (LSG). Right facial nerve electromyography (EMG) data will record after facial nerve damage done and before sacrification at 4th week.The results will be evaluated histopathologically, electrophysiologically and biochemically.
The animals will be randomly divided into two control groups, a healthy control group and a damaged control group, and three experimental groups; 7 rats were assigned to each group as follows;
Recep Tayyip Erdogan University is the lead sponsor of 69 studies on the registry; 13 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
-Thirty-five male Sprague-Dawley rats weighing 200-300 g will be included the study
Exclusion Criteria:
-Rats that are older than 6 months and are not healthy and have impaired facial motor functions will be excluded from the study.
Seven rats will be included randomly in this group. No surgical/medical approach will be applied.
Drug: Methyprednisolon and low level laser theraphy
Facial nerve injury will be created on the right facial nerve. No surgical/medical approach will be applied.
Drug: Methyprednisolon and low level laser theraphy
Facial nerve injury will be created on the right facial nerve. LLLT (Low-Intensity et al.) willl be applied 3 times a week for 4 weeks postoperatively, at 830 nm with an optical power output of 30 mW, an energy density of 4 J/cm2, an irradiation area of 0.116 cm2 and an exposure time of 16 s per spot.
Drug: Methyprednisolon and low level laser theraphy
Facial nerve injury will be created on the right facial nerve. Intraperitoneal methylprednisolone (1mg/kg/day) will be administered every day for 1 week postoperatively.
Drug: Methyprednisolon and low level laser theraphy
Facial nerve injury will be created on the right facial nerve. Laser and steroid treatment will be applied in combination.
Drug: Methyprednisolon and low level laser theraphy
All rats will be anesthetized with ketamine hydrochloride at a dose of 50 mg/kg (i.p) (Ketalar ®, Eczacıbaşı Parke-Davis, İstanbul, Türkiye) and Xylazine HCl (Alfazyne ®, Alfasan International B.V. Woerden, Hollanda) at a dose of 10 mg/kg (intraperitoneal). A right postauricular incision will made under general anesthesia, and an external trunk of the facial nerve will be found. In the DCG and other experimental groups, the facial nerve was dissected, and it will be clamped with an average force of 150 g for about 1 minute. Afterward, the surgical area will be sutured in all rats in the DCG, L, S, and LSG groups. At the end of the 4 weeks of study, tissue samples will be taken from the facial nerve trunk in the control and experimental groups with a second surgical procedure preserved in formalin solution and sent for histopathological and biochemical examination.
Electromyographic Analysis
Measuring the amplitude and latency of the action potential occurring in the nerve with electromyography(On facial nerve)
Time frame: 1 month
Biochemical Analysis
Determination of MDA and GSH levels in blood samples taken
Time frame: 1 month
Plan to share: No
No publications or documents are linked to this record.
Ran from Jan 2021 to primary completion in Jun 2023, 29 months.
How these figures are worked out, and which studies are left out of them.
This study is active, not recruiting, as verified in Dec 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Facial Nerve Injuries
Recep Tayyip Erdogan University